ReP USP - Resultado da busca

Artigo de periodico
Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk (2021)
Ma, Feng; Darabi, Maryam; Lhomme, Marie; Tubeuf, Emilie; Canicio, Aurelie; Brerault, Jean; Medadje, Narcisse; Rached, Fabiana; Serrano Junior, Carlos Vicente ; Santos Filho, Raul Dias dos
Source: Atherosclerosis. Unidade: FM
Subjects: LIPOPROTEÍNAS HDL, COLESTEROL, FATORES DE RISCO, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MA, Feng et al. Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk. Atherosclerosis, v. 324, p. 01-08, 2021Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/53856. Acesso em: 16 nov. 2024.
APA
Ma, F., Darabi, M., Lhomme, M., Tubeuf, E., Canicio, A., Brerault, J., et al. (2021). Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk. Atherosclerosis, 324, 01-08. doi:10.1016/j.atherosclerosis.2021.03.002
NLM
Ma F, Darabi M, Lhomme M, Tubeuf E, Canicio A, Brerault J, Medadje N, Rached F, Serrano Junior CV, Santos Filho RD dos. Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk [Internet]. Atherosclerosis. 2021 ; 324 01-08.[citado 2024 nov. 16 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53856
Vancouver
Ma F, Darabi M, Lhomme M, Tubeuf E, Canicio A, Brerault J, Medadje N, Rached F, Serrano Junior CV, Santos Filho RD dos. Phospholipid transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis is directly correlated with HDL-cholesterol levels and is not associated with cardiovascular risk [Internet]. Atherosclerosis. 2021 ; 324 01-08.[citado 2024 nov. 16 ] Available from: https://observatorio.fm.usp.br/handle/OPI/53856
Trabalho de evento-resumo periodico
Polyunsaturated lipid species of HDL are most strongly affected by genetic apolipoprotein A-I deficiency (2017)
Zakiev, Emil; Rached, Fabiana; Lhomme, Marie; Serrano Júnior, Carlos Vicente; Santos Filho, Raul Dias dos; Chapman, John; Orekhov, Alexander; Kontush, Anatol
Source: Atherosclerosis. Conference titles: EAS Congress. Unidade: FM
Subjects: LIPÍDEOS, LIPOPROTEÍNAS HDL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZAKIEV, Emil et al. Polyunsaturated lipid species of HDL are most strongly affected by genetic apolipoprotein A-I deficiency. Atherosclerosis. Amsterdam: Elsevier. Disponível em: https://doi.org/10.1016/j.atherosclerosis.2017.06.095. Acesso em: 16 nov. 2024. , 2017
APA
Zakiev, E., Rached, F., Lhomme, M., Serrano Júnior, C. V., Santos Filho, R. D. dos, Chapman, J., et al. (2017). Polyunsaturated lipid species of HDL are most strongly affected by genetic apolipoprotein A-I deficiency. Atherosclerosis. Amsterdam: Elsevier. doi:10.1016/j.atherosclerosis.2017.06.095
NLM
Zakiev E, Rached F, Lhomme M, Serrano Júnior CV, Santos Filho RD dos, Chapman J, Orekhov A, Kontush A. Polyunsaturated lipid species of HDL are most strongly affected by genetic apolipoprotein A-I deficiency [Internet]. Atherosclerosis. 2017 ; 263 e22-e23.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.095
Vancouver
Zakiev E, Rached F, Lhomme M, Serrano Júnior CV, Santos Filho RD dos, Chapman J, Orekhov A, Kontush A. Polyunsaturated lipid species of HDL are most strongly affected by genetic apolipoprotein A-I deficiency [Internet]. Atherosclerosis. 2017 ; 263 e22-e23.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2017.06.095
Artigo de periodico
Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease: a randomized placebo-controlled study (2008)
Fernandes, Juliano Lara; Oliveira, Romulo Tadeu Dias de; Mamoni, Ronei Luciano; Coelho, Oatvio Rizzi; Nicolau, José Carlos; Blotta, Maria Heloisa S. L.; Serrano Junior, Carlos Vicente
Source: Atherosclerosis. Unidade: FM
Subjects: INFLAMAÇÃO (REDUÇÃO), CORONARIOPATIA (TERAPIA;IMUNOLOGIA), ARTERIOSCLEROSE (PATOLOGIA;IMUNOLOGIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, Juliano Lara et al. Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease: a randomized placebo-controlled study. Atherosclerosis, v. 196, n. 1, p. 434-442, 2008Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2006.11.032. Acesso em: 16 nov. 2024.
APA
Fernandes, J. L., Oliveira, R. T. D. de, Mamoni, R. L., Coelho, O. R., Nicolau, J. C., Blotta, M. H. S. L., & Serrano Junior, C. V. (2008). Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease: a randomized placebo-controlled study. Atherosclerosis, 196( 1), 434-442. doi:10.1016/j.atherosclerosis.2006.11.032
NLM
Fernandes JL, Oliveira RTD de, Mamoni RL, Coelho OR, Nicolau JC, Blotta MHSL, Serrano Junior CV. Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease: a randomized placebo-controlled study [Internet]. Atherosclerosis. 2008 ; 196( 1): 434-442.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2006.11.032
Vancouver
Fernandes JL, Oliveira RTD de, Mamoni RL, Coelho OR, Nicolau JC, Blotta MHSL, Serrano Junior CV. Pentoxifylline reduces pro-inflammatory and increases anti-inflammatory activity in patients with coronary artery disease: a randomized placebo-controlled study [Internet]. Atherosclerosis. 2008 ; 196( 1): 434-442.[citado 2024 nov. 16 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2006.11.032
Trabalho de evento-resumo periodico
Heterogeneity and molecular mechanisms of the anti-apoptotic activity of HDL subfractions in endothelial human cells (2007)
Souza, Juliana A; Vindis, Cecile; Chantepie, Sandrine; Negre-Salvayre, Anne; Therond, Patrice; Salvayre, Robert; Serrano Junior, Carlos V; Chapman, M. John; Kontush, Anatol
Source: Atherosclerosis. Conference titles: Panamerican Congress of Atherosclerosis. Unidade: FM
Subjects: LIPOPROTEÍNAS (METABOLISMO), CÉLULAS ENDOTELIAIS, APOPTOSE, BIOMARCADORES, BIOLOGIA MOLECULAR, MECANISMOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Juliana A et al. Heterogeneity and molecular mechanisms of the anti-apoptotic activity of HDL subfractions in endothelial human cells. Atherosclerosis. Boston: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 16 nov. 2024. , 2007
APA
Souza, J. A., Vindis, C., Chantepie, S., Negre-Salvayre, A., Therond, P., Salvayre, R., et al. (2007). Heterogeneity and molecular mechanisms of the anti-apoptotic activity of HDL subfractions in endothelial human cells. Atherosclerosis. Boston: Faculdade de Medicina, Universidade de São Paulo.
NLM
Souza JA, Vindis C, Chantepie S, Negre-Salvayre A, Therond P, Salvayre R, Serrano Junior CV, Chapman MJ, Kontush A. Heterogeneity and molecular mechanisms of the anti-apoptotic activity of HDL subfractions in endothelial human cells. Atherosclerosis. 2007 ; 8( 3): 3.[citado 2024 nov. 16 ]
Vancouver
Souza JA, Vindis C, Chantepie S, Negre-Salvayre A, Therond P, Salvayre R, Serrano Junior CV, Chapman MJ, Kontush A. Heterogeneity and molecular mechanisms of the anti-apoptotic activity of HDL subfractions in endothelial human cells. Atherosclerosis. 2007 ; 8( 3): 3.[citado 2024 nov. 16 ]

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em